Published in Drug Week, June 16th, 2006
Valtropin, which is similar to domestic trademarked Eutropin, is a recombinant product originally developed in Korea by LG Life Sciences in 1993 for treatment of GHD Children. Since its successful launch in Korea, it continues to rank as the top market share holder in the Korean domestic market, competing against multinational products.
Since 1998, LG Life Sciences has been upgrading its manufacturing facility...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.